Exchange: NASDAQ·Updated 12:17 PM EDT
ALEC logo

ALEC Alector Inc

$1.96
$0.06
(2.97%)
Today
EarningsNov 5
Mkt Cap$225.55M
Vol182,326.00

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
46

Neutral Sentiment

How do you feel about ALEC?

BiotechButterflies
$ALEC ... hoping for a good performance at Cantor Fitz.... cool early stage assets... hanging in for a bit more....
1

Advertisement|Remove ads.